These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 15180351)
1. Probiotics reduce the CD34+ hemopoietic precursor cell increased traffic in allergic subjects. Mastrandrea F; Coradduzza G; Serio G; Minardi A; Manelli M; Ardito S; Muratore L Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):118-22. PubMed ID: 15180351 [TBL] [Abstract][Full Text] [Related]
2. CD34+ hemopoietic precursor and stem cells traffic in peripheral blood of celiac patients is significantly increased but not directly related to epithelial damage severity. Mastrandrea F; Semeraro FP; Coradduzza G; Manelli M; Scarcia G; Pezzuto F; Serio G Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):90-103. PubMed ID: 19334373 [TBL] [Abstract][Full Text] [Related]
3. Increased CD34+ cell peripheral traffic appears to be an unique feature of the allergic inflammation. Mastrandrea F; Coradduzza G; Resta F; Cadario G; Rollo MA; Marengo F; Mazza P; Pajno G; Di Pasquale G; Minardi A; Scarcia G; Serio G Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):30-3. PubMed ID: 15745375 [TBL] [Abstract][Full Text] [Related]
4. Use of probiotic bacteria for prevention and therapy of allergic diseases: studies in mouse model of allergic sensitization. Di Felice G; Barletta B; Butteroni C; Corinti S; Tinghino R; Colombo P; Boirivant M J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S130-2. PubMed ID: 18806704 [TBL] [Abstract][Full Text] [Related]
5. Progenitor egress from the bone marrow after allergen challenge: role of stromal cell-derived factor 1alpha and eotaxin. Dorman SC; Babirad I; Post J; Watson RM; Foley R; Jones GL; O'Byrne PM; Sehmi R J Allergy Clin Immunol; 2005 Mar; 115(3):501-7. PubMed ID: 15753896 [TBL] [Abstract][Full Text] [Related]
6. CD34+ cells in peripheral blood of healthy human beings and allergic subjects: clue to acute and minimal persistent inflammation. Mastrandrea F; Coradduzza G; De Vita L; Minardi A; Scarcia G; Marcucci F; Parmiani S Allergol Immunopathol (Madr); 2002; 30(4):209-17. PubMed ID: 12199965 [TBL] [Abstract][Full Text] [Related]
8. Differential immunomodulating effects of inactivated probiotic bacteria on the allergic immune response. Rasche C; Wolfram C; Wahls M; Worm M Acta Derm Venereol; 2007; 87(4):305-11. PubMed ID: 17598032 [TBL] [Abstract][Full Text] [Related]
9. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. Kuitunen M; Kukkonen K; Juntunen-Backman K; Korpela R; Poussa T; Tuure T; Haahtela T; Savilahti E J Allergy Clin Immunol; 2009 Feb; 123(2):335-41. PubMed ID: 19135235 [TBL] [Abstract][Full Text] [Related]
10. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Zeng J; Li YQ; Zuo XL; Zhen YB; Yang J; Liu CH Aliment Pharmacol Ther; 2008 Oct; 28(8):994-1002. PubMed ID: 18671775 [TBL] [Abstract][Full Text] [Related]
11. Alterations of food antigen-specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia. Zuo XL; Li YQ; Li WJ; Guo YT; Lu XF; Li JM; Desmond PV Clin Exp Allergy; 2007 Jun; 37(6):823-30. PubMed ID: 17517095 [TBL] [Abstract][Full Text] [Related]
12. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Jain PK; McNaught CE; Anderson AD; MacFie J; Mitchell CJ Clin Nutr; 2004 Aug; 23(4):467-75. PubMed ID: 15297081 [TBL] [Abstract][Full Text] [Related]
13. Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model. Kim JY; Choi YO; Ji GE J Microbiol Biotechnol; 2008 Aug; 18(8):1393-400. PubMed ID: 18756099 [TBL] [Abstract][Full Text] [Related]
14. Studies on Bacillus subtilis and Lactobacillus acidophilus, as potential probiotics, on the immune response and resistance of Tilapia nilotica (Oreochromis niloticus) to challenge infections. Aly SM; Abdel-Galil Ahmed Y; Abdel-Aziz Ghareeb A; Mohamed MF Fish Shellfish Immunol; 2008 Jul; 25(1-2):128-36. PubMed ID: 18450477 [TBL] [Abstract][Full Text] [Related]
15. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients. Todisco E; Castagna L; Sarina B; Mazza R; Magagnoli M; Balzarotti M; Nozza A; Siracusano L; Timofeeva I; Anastasia A; Demarco M; Santoro A Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558 [TBL] [Abstract][Full Text] [Related]
16. Kinetics and immunophenotypic characterization of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation. Albo C; de la Fuente J; Ares C; Alonso C; Feteira E Haematologica; 2004 Jul; 89(7):845-51. PubMed ID: 15257937 [TBL] [Abstract][Full Text] [Related]
17. FOXP3 mRNA expression at 6 months of age is higher in infants who develop atopic dermatitis, but is not affected by giving probiotics from birth. Taylor AL; Hale J; Hales BJ; Dunstan JA; Thomas WR; Prescott SL Pediatr Allergy Immunol; 2007 Feb; 18(1):10-9. PubMed ID: 17295794 [TBL] [Abstract][Full Text] [Related]
18. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426 [TBL] [Abstract][Full Text] [Related]
19. Early markers of allergic disease in a primary prevention study using probiotics: 2.5-year follow-up phase. Prescott SL; Wiltschut J; Taylor A; Westcott L; Jung W; Currie H; Dunstan JA Allergy; 2008 Nov; 63(11):1481-90. PubMed ID: 18925885 [TBL] [Abstract][Full Text] [Related]
20. Accuracy of US Food and Drug Administration-cleared IgE antibody assays in the presence of anti-IgE (omalizumab). Hamilton RG J Allergy Clin Immunol; 2006 Apr; 117(4):759-66. PubMed ID: 16630931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]